Patent details

EP1948620 Title: DIHYDROGEN PHOSPHATE SALT OF A PROSTAGLANDIN D2 RECEPTOR ANTAGONIST

Basic Information

Publication number:
EP1948620
PCT Application Number:
PCT/US/2006/039901
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068258367
PCT Publication Number:
WO/2007/047378
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIHYDROGEN PHOSPHATE SALT OF A PROSTAGLANDIN D2 RECEPTOR ANTAGONIST
French Title of Invention:
SEL DIHYDROGENE PHOSPHATE D'UN ANTAGONISTE DU RECEPTEUR DE LA PROSTAGLANDINE D2
German Title of Invention:
DIHYDROGENPHOSPHATSALZ EINES PROSTAGLANDIN-D2-REZEPTOR-ANTAGONISTEN
SPC Number:

Dates

Filing date:
12/10/2006
Grant date:
20/03/2013
EP Publication Date:
20/03/2013
PCT Publication Date:
26/04/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/07/2008
EP B1 Publication Date:
20/03/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/10/2014
Expiration date:
12/10/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/10/2006
 
 

Name:
AVENTIS PHARMACEUTICALS INC.
Address:
SOMERSET CORPORATE BOULEVARD 300, BRIDGEWATER NEW JERSEY 08807, United States (US)

Agent

Name:
ARONOVA S.A.
From:
18/06/2013
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
LANGEVIN Beverly
Address:
United States (US)

2

Name:
ORTON Edward
Address:
United States (US)

3

Name:
SHERER Daniel
Address:
United States (US)

Priority

Priority Number:
726290 P
Priority Date:
13/10/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 239/46;
Filing date Document type Number of pages